Martin A. Fehr

Sankt Gallen, SG, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.

Journal: Haematologica
Published: June 02, 2026

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Journal: Blood advances
Published: January 13, 2026

Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.

Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.

Journal: Bone marrow transplantation
Published: July 27, 2025

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma.

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma.

Journal: HemaSphere
Published: June 30, 2025

Advancement of clinical practice in delivering CAR T-cell therapy: impact on healthcare resource utilization and comparison with autologous stem cell transplantation in patients with relapsed/refractory large B-cell lymphomas.

Advancement of clinical practice in delivering CAR T-cell therapy: impact on healthcare resource utilization and comparison with autologous stem cell transplantation in patients with relapsed/refractory large B-cell lymphomas.

Journal: Annals of hematology
Published: April 25, 2025

The variety and origin of materials accreted by Bennu's parent asteroid.

The variety and origin of materials accreted by Bennu's parent asteroid.

Journal: Nature astronomy
Published: November 21, 2024

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Journal: Swiss medical weekly
Published: October 28, 2024

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).

Journal: EClinicalMedicine
Published: May 18, 2023

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.

Journal: Blood cancer journal
Published: March 26, 2023

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Journal: Leukemia
Published: May 24, 2022

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.

Journal: Hematological oncology
Published: November 21, 2020

Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.

Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.

Journal: Annals of hematology
Published: October 13, 2020
Showing 1-12 of 31

Last Updated: 09/26/2026